495 related articles for article (PubMed ID: 9000455)
1. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.
Hu L; Côté SL; Cuello AC
Exp Neurol; 1997 Jan; 143(1):162-71. PubMed ID: 9000455
[TBL] [Abstract][Full Text] [Related]
2. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
Garofalo L; Cuello AC
Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
[TBL] [Abstract][Full Text] [Related]
4. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1.
Casamenti F; Milan F; Pepeu G
Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662
[TBL] [Abstract][Full Text] [Related]
5. In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration.
Debeir T; Marien M; Ferrario J; Rizk P; Prigent A; Colpaert F; Raisman-Vozari R
Exp Neurol; 2004 Dec; 190(2):384-95. PubMed ID: 15530877
[TBL] [Abstract][Full Text] [Related]
6. Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro.
Hartikka J; Hefti F
J Neurosci Res; 1988; 21(2-4):352-64. PubMed ID: 3216428
[TBL] [Abstract][Full Text] [Related]
7. Evidence for nerve growth factor-ganglioside interaction in forebrain cholinergic neurons.
Cuello AC; Garofalo L; Maysinger D
Acta Neurobiol Exp (Wars); 1990; 50(4-5):451-60. PubMed ID: 2130661
[TBL] [Abstract][Full Text] [Related]
8. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates.
Koliatsos VE; Clatterbuck RE; Nauta HJ; Knüsel B; Burton LE; Hefti FF; Mobley WC; Price DL
Ann Neurol; 1991 Dec; 30(6):831-40. PubMed ID: 1789695
[TBL] [Abstract][Full Text] [Related]
9. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
Mufson EJ; Lavine N; Jaffar S; Kordower JH; Quirion R; Saragovi HU
Exp Neurol; 1997 Jul; 146(1):91-103. PubMed ID: 9225742
[TBL] [Abstract][Full Text] [Related]
10. Does senile impairment of cholinergic system in rats concern only disturbances in cholinergic phenotype or the progressive degeneration of neuronal cell bodies?
Niewiadomska G; Wyrzykowska J; Chechłacz M
Acta Biochim Pol; 2000; 47(2):313-30. PubMed ID: 11051196
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.
Garofalo L; Cuello AC
J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166
[TBL] [Abstract][Full Text] [Related]
12. Distribution of nerve growth factor-like immunoreactive neurons in the adult rat brain following colchicine treatment.
Conner JM; Varon S
J Comp Neurol; 1992 Dec; 326(3):347-62. PubMed ID: 1469118
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor mRNA-containing cells are distributed within regions of cholinergic neurons in the rat basal forebrain.
Lauterborn JC; Isackson PJ; Gall CM
J Comp Neurol; 1991 Apr; 306(3):439-46. PubMed ID: 1865003
[TBL] [Abstract][Full Text] [Related]
14. Direct, complex effects of estrogens on basal forebrain cholinergic neurons.
Bora SH; Liu Z; Kecojevic A; Merchenthaler I; Koliatsos VE
Exp Neurol; 2005 Aug; 194(2):506-22. PubMed ID: 15893308
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone induces TrkA and p75NTR immunoreactivity in the cerebral cortex and hippocampus.
Shi B; Mocchetti I
Exp Neurol; 2000 Apr; 162(2):257-67. PubMed ID: 10739632
[TBL] [Abstract][Full Text] [Related]
16. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA.
Winkler J; Thal LJ
Exp Neurol; 1995 Dec; 136(2):234-50. PubMed ID: 7498413
[TBL] [Abstract][Full Text] [Related]
17. Degeneration of the basalocortical pathway from the cortex induces a functional increase in galaninergic markers in the nucleus basalis magnocellularis of the rat.
Barbelivien A; Vaussy C; Marchalant Y; Maubert E; Bertrand N; Beley A; Roussel S; Mackenzie ET; Dauphin F
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1255-66. PubMed ID: 15545921
[TBL] [Abstract][Full Text] [Related]
18. Role of nerve growth factor in the expression of trkA mRNA in cultured embryonic rat basal forebrain cholinergic neurons.
Kojima M; Ikeuchi T; Hatanaka H
J Neurosci Res; 1995 Dec; 42(6):775-83. PubMed ID: 8847739
[TBL] [Abstract][Full Text] [Related]
19. Effect of nerve growth factor on the elongation of neurites from axotomized rat embryonic septal-basal forebrain neurons: an in vitro analysis.
Schinstine M; Cornbrooks CJ
J Neurosci Res; 1989 Aug; 23(4):371-83. PubMed ID: 2549266
[TBL] [Abstract][Full Text] [Related]
20. Effect of the thyrotropin releasing hormone analogue posatirelin (RGH 2202) on microanatomical changes induced by lesions of the nucleus basalis magnocellularis in the rat.
Panocka I; Coppi G; Maggioni A; Olgiati V; Sabbatini M; Amenta F
Drugs Exp Clin Res; 1997; 23(1):13-23. PubMed ID: 9093818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]